Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of TS-1, Cisplatin & RAD001 (Everolimus)

NCT01096199 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01096199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01096199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of TS-1, Cisplatin & RAD001 (Everolimus)
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1
Overall status
Terminated
Start date
Not reported
Completion date
Not reported
Enrollment
35
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer